Skip to main content

Table 2 Antimicrobial sensitivity profile for Pseudomonas aeruginosa from a paediatric patient over an 8 year period

From: A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa

 

CLSI Guidelines

EUCAST Guidelines

 

Disk content (μg)

2006

2007

2008

2010

2011

2012

Disk content (μg)

2013

2014

  

11/8

23/8

6/8

5/5

14/12

22/4

10/4

 

26/3

6/6

30/9

20/12

23/1

23/1a

11/9a

Drug

                

 Ofloxacin

5

S

S

NT

NT

NT

NT

NT

0

NT

NT

NT

NT

NT

NT

NT

 Pipercillin/ Tazobactum

100/10

S

S

S

S

S

S

S

36

S

S

S

S

S

R

S

 Ceftazidime

30

S

S

S

S

S

S

S

10

S

S

S

S

S

S

S

 Tobramycin

10

S

S

S

S

S

S

S

10

S

S

S

S

S

S

S

 Ciprofloxacin

5

NT

S

NT

S

S

S

S

5

S

S

S

S

S

S

S

 Amikacin

30

NT

S

NT

NT

NT

NT

NT

30

NT

NT

NT

NT

NT

NT

NT

 Aztreoman

30

NT

S

NT

NT

NT

NT

S

30

S

I

I

I

I

I

I

 Colistin (E-Test)

10

NT

S

NT

NT

NT

NT

NT

10

NT

NT

S

S

S

S

S

 Imipenem

10

NT

S

NT

NT

NT

NT

NT

10

NT

NT

NT

NT

NT

NT

NT

 Meropenem

10

NT

S

S

S

S

S

S

10

S

S

S

S

S

S

S

  1. S Susceptible, I Intermediate, R Resistant and NT Not Tested
  2. aP. aeruginosa isolated from antral washing